Professor Roger Daly Related News
Taking the fingerprint of basal breast cancer
MEDIA RELEASE:
29 Sep 2010
Australian researchers have used sophisticated new protein screening technology to profile basal breast cancer, a particularly aggressive sub-type of breast cancer, identifying specific targets for future treatments.
Falko Hochgräfe wins proteomics award
29 Sep 2010
Dr Falko Hochgräfe, postdoctoral researcher at Garvan, was awarded the Human Proteome Organisation (HUPO) Young Guns Early Career Research Award last week. Fifteen of the field’s brightest young researchers were shortlisted from around the world to present their findings at HUPO’s 9th Annual World Congress held in Sydney.
First step towards switching off breast cancer and leukaemia
MEDIA RELEASE:
08 Aug 2008
Garvan scientists have identified a way to ‘switch off’ a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia. The molecule, known as Gab2, operates downstream of a major breast cancer oncogene, HER2, the target of the drug Herceptin.
